信息通信技术与政策2024，Vol.50Issue(3)：79-82,4.DOI:10.12267/j.issn.2096-5931.2024.03.012
我国生物医药行业数字化转型瓶颈及应对建议
Bottlenecks of digital transformation in China's biopharmaceutical industry and corresponding suggestions
王晓玲1
作者信息
- 1. 中国信息通信研究院信息化与工业化融合研究所,北京 100191
- 折叠
摘要
Abstract
As an emerging emerging industry in China,the biopharmaceutical industry is facing difficulties both internally and externally.Digital transformation has become a necessary path for overcoming adversities.However,the digital transformation of the biopharmaceutical industry is currently constrained by four major bottlenecks:insufficient data foundation,relatively lagging policy regulation,lack of targeted evaluation systems,and shortage of compound talents.The progress of transformation is relatively backward.It is recommended to accelerate the digital transformation of the biopharmaceutical industry by unifying data standards,establishing public data resource systems,innovating regulatory models,constructing transformation evaluation systems,and cultivating talent teams.关键词
数字化转型/生物医药行业/制药/瓶颈/建议Key words
digital transformation/biopharmaceutical industry/pharmacy/bottleneck/suggestion分类
管理科学引用本文复制引用
王晓玲..我国生物医药行业数字化转型瓶颈及应对建议[J].信息通信技术与政策,2024,50(3):79-82,4.
